Literature DB >> 7527999

Analogues of peptide 9-21 of glycoprotein D of herpes simplex virus and their binding to group VII monoclonal antibodies.

S Welling-Wester1, M Feijlbrief, D G Koedijk, J W Drijfhout, W J Weijer, A J Scheffer, G W Welling.   

Abstract

Several analogues of the amino acid sequence of peptide 9-21 of glycoprotein D of herpes simplex virus type 1 (HSV-1) were synthesized and investigated for reactivity with different group VII monoclonal antibodies, Mabs LP14, ID3, 170, HD4, A16, EII-24 and Ev-10, in a competition enzyme-linked immunosorbent assay (ELISA). Replacement of Arg at position 16 by His resulted in a loss of binding with the group VII Mabs. Substitution of Pro at residue 14 by Leu gave a reduced binding for a number of Mabs and loss of binding for Mab A16. Substitution of Lys at position 10 by Glu gave reduced binding for three out of the seven Mabs. In addition substitutions of Met at position 11 by norleucine and oxidized Met were studied. The boundaries of the epitope cluster were mapped by studying synthetic variants of peptide 9-21 which were shorter either at the C-terminus or at the N-terminus, or both. Peptide 10-18 and peptide 9-17 were the shortest peptides, which were still reactive with the group VII Mabs. Mab HD4 requires the N-terminus of peptide 9-21 for effective binding, while for binding of other Mabs contribution of the residues in the C-terminal part of this peptide is more important.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7527999     DOI: 10.1007/bf01379135

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  31 in total

1.  Herpes simplex virus glycoprotein D is sufficient to induce spontaneous pH-independent fusion in a cell line that constitutively expresses the glycoprotein.

Authors:  G Campadelli-Fiume; E Avitabile; S Fini; D Stirpe; M Arsenakis; B Roizman
Journal:  Virology       Date:  1988-10       Impact factor: 3.616

2.  1H-NMR assignment and secondary structure of a herpes simplex virus glycoprotein D-1 antigenic domain.

Authors:  M P Williamson; M J Hall; B K Handa
Journal:  Eur J Biochem       Date:  1986-08-01

3.  Immunological properties of multiple repeats of a linear epitope of herpes simplex virus type 1 glycoprotein D.

Authors:  J R Van der Ploeg; J W Drijfhout; M Feijlbrief; W Bloemhoff; G W Welling; S Welling-Wester
Journal:  J Immunol Methods       Date:  1989-11-30       Impact factor: 2.303

4.  Structural properties and reactivity of N-terminal synthetic peptides of herpes simplex virus type 1 glycoprotein D by using antipeptide antibodies and group VII monoclonal antibodies.

Authors:  D L Bosch; H J Geerligs; W J Weijer; M Feijlbrief; G W Welling; S Welling-Wester
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

5.  Fine mapping of antigenic site II of herpes simplex virus glycoprotein D.

Authors:  V J Isola; R J Eisenberg; G R Siebert; C J Heilman; W C Wilcox; G H Cohen
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

6.  Localization and synthesis of an antigenic determinant of herpes simplex virus glycoprotein D that stimulates the production of neutralizing antibody.

Authors:  G H Cohen; B Dietzschold; M Ponce de Leon; D Long; E Golub; A Varrichio; L Pereira; R J Eisenberg
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

7.  Glycoprotein D protects mice against lethal challenge with herpes simplex virus types 1 and 2.

Authors:  D Long; T J Madara; M Ponce de Leon; G H Cohen; P C Montgomery; R J Eisenberg
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

8.  Soluble forms of herpes simplex virus glycoprotein D bind to a limited number of cell surface receptors and inhibit virus entry into cells.

Authors:  D C Johnson; R L Burke; T Gregory
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

9.  Virus neutralizing activity induced by synthetic peptides of glycoprotein D of herpes simplex virus type 1, selected by their reactivity with hyperimmune sera from mice.

Authors:  H J Geerligs; C H Kocken; J W Drijfhout; W J Weijer; W Bloemhoff; J B Wilterdink; G W Welling; S Welling-Wester
Journal:  J Gen Virol       Date:  1990-08       Impact factor: 3.891

10.  Identification and expression of the human herpesvirus 6 glycoprotein H and interaction with an accessory 40K glycoprotein.

Authors:  D X Liu; U A Gompels; J Nicholas; C Lelliott
Journal:  J Gen Virol       Date:  1993-09       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.